Periocular neurofibrosarcoma in a horse

Veterinary Ophthalmology

Volumn 4, Issue 4, 2001, Pages 237-241

  Strubbe, D Todd ^a  

^a Animal Eye Specialty Clinic   (United States)

Author keywords

Cisplatin; Horse; Neurofibrosarcoma

Indexed keywords

EQUUS CABALLUS;

ANTINEOPLASTIC AGENT; CISPLATIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HORSE; HORSE DISEASE; NEUROFIBROSARCOMA; ORBIT TUMOR; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HORSE DISEASES; HORSES; NEUROFIBROSARCOMA; ORBITAL NEOPLASMS;

EID: 0035750317     PISSN: 14635216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-5216.2001.00184.x     Document Type: Article

References (32)

1. Blodi FC, Ramsey FK. Ocular tumors in domestic animals. American Journal of Ophthalmology 1967; 64: 627-633.
2. Baker JR, Leyland A. Histological survey of tumours of the horse, with particular reference to those of the skin. Veterinary Record 1975; 96: 419-422.
3. Lavach JD. Neoplasia of the equine eye, adnexa, and orbit: a review of 68 cases. Journal of the American Veterinary Medical Association 1977; 170: 202-203.
4. Rebhun WC, Bertone A. Equine lymphosarcoma. Journal of the American Veterinary Medical Association 1984; 184: 720-721.
5. Moore PF, Hacker DV, Buyukmihci NC. Ocular angiosarcoma in the horse. Morphological and immunohistochemical studies. Veterinary Pathology 1986; 23: 240-244.
6. Dugan SJ. Ocular neoplasia. Veterinary Clinics of North America: Equine Practice 1992; 8: 609-626.
7. Hance SR. Neoplasia. Veterinary Clinics of North America: Equine Practice 1993; 9: 213-234.
8. Knottenbelt DC, Kelly DF. The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999 Veterinary Ophthalmology 2000 3: 169-191.
9. nd edn. (eds Theilen GH, Madewell BR) Lea & Febiger, Philadelphia, 1987; 233.
10. 192Iridium interstitial brachytherapy for equine periocular tumours. Treatment results and prognostic factors in 115 horses. Equine Veterinary Journal 1994; 27: 117-121.
11. Lewis RE. Radon implant therapy of squamous cell carcinoma and equine sarcoid. Proceedings of the 10th Annual Convention of the American Association of Equine Practitioners 1964; 10: 217-234.
12. Wyn-Jones G. Treatment of periocular tumours of horses using radioactive gold 198 grains. Equine Veterinary Journal 1979; 11: 3-10.
13. Turrel JM, Koblik PD. Techniques of afterloading iridium-192 interstitial brachytherapy in veterinary medicine. Veterinary Radiology 1983; 24: 278-283.
14. Wyn-Jones G. Treatment of equine cutaneous neoplasia by radiotherapy using iridium 192 linear sources. Equine Veterinary Journal 1983; 15: 361-365.
15. 222Rn for treatment of periocular fibrous connective tissue sarcomas in the horse. Journal of the American Veterinary Medical Association 1982; 180: 310-312.
16. 90Sr for treatment of periocular squamous cell carcinoma in the horse. Journal of the American Veterinary Medical Association 1982; 180: 307-309.
17. Farris HE, Frauenfelder FT, Mason CT. Cryotherapy of equine sarcoid and other lesions. Veterinary Medicine and Small Animal Clinician 1976; 71: 325-329.
18. Lane JG. The treatment of equine sarcoids by cryosurgery. Equine Veterinary Journal 1977; 9: 127-133.
19. Lavach JD, Sullins KE, Roberts SM et al. BCG treatment of periocular sarcoid. Equine Veterinary Journal 1985; 17: 445-448.
20. Neuman SM, Kaineier RA, Severine GA. Reaction of normal equine eyes to radio-frequency current induced hyperthermia. American Journal of Veterinary Research 1982; 43: 1938-1944.
21. Theon AP, Pascoe JR, Carlson GP et al. Intratumoral chemotherapy with cisplatin in oily emulsion in horses. Journal of the American Veterinary Medical Association 1993; 202: 261-267.
22. Theon AP, Pascoe JR, Krag DN. Perioperative intratumoral administration of cisplatin for treatment of cutaneous tumors in equidae. Journal of the American Veterinary Medical Association 1994; 205: 1170-1176.
23. Gelatt KN. Blepharoplastic procedures in horses. Journal of the American Veterinary Medical Association 1967; 151: 27-44.
24. Davidson MG. Equine ophthalmology. In: Veterinary Ophthalmology, 2nd edn. (ed. Gelatt KN) Lea & Febiger, Philadelphia, 1991; 576-610.
25. Marti E, Lazary S, Antczak DF et al. Report of the first international workshop on equine sarcoid. Equine Veterinary Journal 1993; 25: 397-407.
26. Jubb KVF, Huxtable CR. The nervous system. In: Pathology of Domestic Animals, Vol. 1, 4th edn. (eds Jubb VF, Kennedy PC, Palmer N) Harcourt Brace Jovanovich, New York, 1993; 267-439.
27. Loehrer PJ, Einhorn LH. Cisplatin. Annuals of Internal Medicine 1984; 100: 704-713.
28. Davis LE. Cisplatin, a new antineoplastic drug in veterinary medicine. Journal of the American Veterinary Medical Association 1985; 186: 288-290.
29. Knapp DW, Richardson RC, Bonney PL et al. Cisplatin therapy in 41 dogs with malignant tumors. Journal of Veterinary Internal Medicine 1988; 2: 41-46.
30. Collins JM. Pharmacologic rationale for regional drug delivery. Journal of Clinical Oncology 1984; 2: 498-504.
31. Theon AP, Pascoe JR, Madigan JE et al. Comparison of intratumoral administration of cisplatin versus bleomycin for treatment of periocular squamous cell carcinomas in horses. American Journal of Veterinary Research 1997; 58: 431-436.
32. Takahashi T, Kono K, Yamaguchi T. Enhancement of the cancer chemotherapeutic effect by anticancer agents in the form of fat emulsion. Tohoku Journal of Experimental Medicine 1977; 123: 235-246.